New AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC
As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing.
The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.
Download the whitepaper to learn:
- How the body responds to SARS-COV-2
- The different approaches to antibody testing
- The UK-RTC Abc-19 Rapid Test
- The link between antibodies and immunity
- The route towards therapies and immunisation
Please access the complete whitepaper for this device here.